Phase II trial of dose-dense paclitaxel, cisplatin, 5-fluorouracil, and leucovorin with filgrastim support in patients with squamous cell carcinoma of the head and neck. [electronic resource]
Producer: 20040824Description: 768-75 p. digitalISSN:- 0008-543X
- Adult
- Aged
- Antineoplastic Combined Chemotherapy Protocols -- adverse effects
- Carcinoma, Squamous Cell -- drug therapy
- Cisplatin -- administration & dosage
- Drug Administration Schedule
- Female
- Filgrastim
- Fluorouracil -- administration & dosage
- Granulocyte Colony-Stimulating Factor -- administration & dosage
- Head and Neck Neoplasms -- drug therapy
- Humans
- Infusions, Intravenous
- Leucovorin -- administration & dosage
- Male
- Middle Aged
- Neutropenia -- chemically induced
- Paclitaxel -- administration & dosage
- Recombinant Proteins
- Sepsis -- chemically induced
- Survival Analysis
- Treatment Outcome
No physical items for this record
Publication Type: Clinical Trial; Clinical Trial, Phase II; Journal Article
There are no comments on this title.
Log in to your account to post a comment.